{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T12:12:10Z","timestamp":1784808730644,"version":"3.55.0"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T00:00:00Z","timestamp":1753920000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>22q11.2 deletion syndrome (22q11.2DS) is a complex and heterogeneous genetic disorder. While short stature is well-documented, data on weight excess in pediatric patients remain sparse and conflicting.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To evaluate the prevalence of overweight and obesity in children and adolescents with 22q11.2DS when compared to the general Italian pediatric population and identify risk factors and periods of critical weight gain.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this single-center, retrospective study, 61 children with molecularly confirmed 22q11.2DS were followed up for 441 patient-years. Anthropometric data were evaluated and compared to national surveillance databases (\u201cOKKio alla Salute\u201d and \u201cHBSC\u201d). Risk factors for overweight and obesity were identified by univariate and multivariate analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>While overweight prevalence in 22q11.2DS patients did not differ significantly from that in the general population, obesity had a bimodal age distribution with peaks at 11 and 17 years. Both neuropsychiatric comorbidities and the use of psychoactive medication were significantly associated with an increased risk of overweight and obesity. In multivariate analysis, the use of psychoactive medication was the only independent risk factor.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Obesity in 22q11.2DS may not be syndrome-intrinsic but is heavily influenced by pharmacological treatment. Identification of vulnerable periods and modifiable risk factors is crucial. A preventive, multidisciplinary approach with metabolic screening and cautious use of psychotropic medication is warranted to avoid obesity risk in this population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2025.1628796","type":"journal-article","created":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T04:10:50Z","timestamp":1753935050000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Understanding obesity in children with 22q11.2 deletion syndrome"],"prefix":"10.3389","volume":"16","author":[{"given":"Walter Maria","family":"Sarli","sequence":"first","affiliation":[{"name":"Immunology Unit, Meyer Children\u2019s Hospital IRCCS","place":["Florence, Italy"]},{"name":"Department of Health Sciences, University of Florence","place":["Florence, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Cerutti","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, University of Florence","place":["Florence, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Pontone","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, University of Florence","place":["Florence, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Guarnieri","sequence":"additional","affiliation":[{"name":"Immunology Unit, Meyer Children\u2019s Hospital IRCCS","place":["Florence, Italy"]},{"name":"Department of Health Sciences, University of Florence","place":["Florence, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Soldovieri","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, University of Florence","place":["Florence, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Giotta","sequence":"additional","affiliation":[{"name":"PhD School in Public Health, Clinical Medicine and Oncology, Department of Precision and Regenerative Medicine and Ionian Area, School of Medicine, University of Bari Aldo Moro","place":["Bari, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Ricci","sequence":"additional","affiliation":[{"name":"Immunology Unit, Meyer Children\u2019s Hospital IRCCS","place":["Florence, Italy"]},{"name":"Department of Health Sciences, University of Florence","place":["Florence, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Azzari","sequence":"additional","affiliation":[{"name":"Immunology Unit, Meyer Children\u2019s Hospital IRCCS","place":["Florence, Italy"]},{"name":"Department of Health Sciences, University of Florence","place":["Florence, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Stagi","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, University of Florence","place":["Florence, Italy"]},{"name":"Diabetology and Endocrinology Unit, Meyer Children's Hospital IRCCS","place":["Florence, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,7,31]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"15071","DOI":"10.1038\/nrdp.2015.71","article-title":"22q11.2 deletion syndrome","volume":"1","author":"McDonald-McGinn","year":"2015","journal-title":"Nat Rev Dis Primers"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1097\/00125817-200101000-00006","article-title":"Phenotype of the 22q11.2 deletion in individuals identified through an affected relative: cast a wide FISHing net","volume":"3","author":"McDonald-McGinn","year":"2001","journal-title":"Genet Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.35.9.789-a","article-title":"The annual incidence of DiGeorge\/velocardiofacial syndrome","volume":"35","author":"Devriendt","year":"1998","journal-title":"J Med Genet"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1136\/adc.79.4.348","article-title":"A population study of chromosome 22q11 deletions in infancy","volume":"79","author":"Goodship","year":"1998","journal-title":"Arch Dis Child"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1542\/peds.112.1.101","article-title":"A population-based study of the 22q11.2 deletion: phenotype, incidence, and contribution to major birth defects in the population","volume":"112","author":"Botto","year":"2003","journal-title":"Pediatrics"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1136\/adc.2003.026880","article-title":"Incidence and prevalence of the 22q11 deletion syndrome: a population-based study in Western Sweden","volume":"89","author":"Oskarsd\u00f3ttir","year":"2004","journal-title":"Arch Dis Child"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.9778\/cmajo.20200294","article-title":"Estimate of the contemporary live-birth prevalence of recurrent 22q11.2 deletions: a cross-sectional analysis from population-based newborn screening","volume":"9","author":"Blagojevic","year":"2021","journal-title":"CMAJ Open"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1203382","article-title":"Chromosomal microarray versus karyotyping for prenatal diagnosis","volume":"367","author":"Wapner","year":"2012","journal-title":"N Engl J Med"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1002\/pd.4613","article-title":"Prevalence of recurrent pathogenic microdeletions and microduplications in over 9500 pregnancies","volume":"35","author":"Grati","year":"2015","journal-title":"Prenat Diagn"},{"key":"B10","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1093\/hmg\/9.4.489","article-title":"Chromosome 22-specific low copy repeats and the 22q11.2 deletion syndrome: genomic organization and deletion endpoint analysis","volume":"9","author":"Shaikh","year":"2000","journal-title":"Hum Mol Genet"},{"key":"B11","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1136\/jmg.34.10.798","article-title":"Spectrum of clinical features associated with interstitial chromosome 22q11 deletions: a European collaborative study","volume":"34","author":"Ryan","year":"1997","journal-title":"J Med Genet"},{"key":"B12","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1089\/gte.1997.1.99","article-title":"The 22q11.2 deletion: screening, diagnostic workup, and outcome of results; report on 181 patients","volume":"1","author":"McDonald-McGinn","year":"1997","journal-title":"Genet Test"},{"key":"B13","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.jpeds.2011.02.039","article-title":"Practical guidelines for managing patients with 22q11.2 deletion syndrome","volume":"159","author":"Bassett","year":"2011","journal-title":"J Pediatr"},{"key":"B14","first-page":"11","article-title":"The Philadelphia story: the 22q11.2 deletion: report on 250 patients","volume":"10","author":"McDonald-McGinn","year":"1999","journal-title":"Genet Couns"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.c.31435","article-title":"Developmental trajectories in 22q11.2 deletion","volume":"169","author":"Swillen","year":"2015","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.1320420131","article-title":"Late-Onset psychosis in the velo-cardio-facial syndrome","volume":"42","author":"Shprintzen","year":"1992","journal-title":"Am J Med Genet"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1542\/peds.101.5.929","article-title":"Growth hormone deficiency in patients with 22q11.2 deletion: expanding the phenotype","volume":"101","author":"Weinzimer","year":"1998","journal-title":"Pediatrics"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1159\/000086745","article-title":"Endocrine manifestations of chromosome 22q11.2 microdeletion syndrome","volume":"63","author":"Choi","year":"2005","journal-title":"Horm Res"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1159\/000096421","article-title":"Parathyroid gland dysfunction in 22q11.2 deletion syndrome","volume":"67","author":"Al-Jenaidi","year":"2007","journal-title":"Horm Res"},{"key":"B20","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/B978-1-4557-4858-7.00019-6","article-title":"Disorders of growth hormone\/insulin-like growth factor secretion and action","volume-title":"Pediatric Endocrinology","author":"Backeljauw","year":"2014"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1097\/00125817-200101000-00007","article-title":"Auxological evaluation in patients with DiGeorge\/velocardiofacial syndrome (deletion 22q11.2 syndrome)","volume":"3","author":"Digilio","year":"2001","journal-title":"Genet Med"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.30984","article-title":"Clinical features of 78 adults with 22q11 Deletion Syndrome","volume":"138","author":"Bassett","year":"2005","journal-title":"Am J Med Genet A"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3390\/genes13112038","article-title":"Adult height, 22q11.2 deletion extent, and short stature in 22q11.2 deletion syndrome","volume":"13","author":"Heung","year":"2022","journal-title":"Genes (Basel)"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/s41366-024-01685-2","article-title":"Obesity and metabolic syndrome in adults with a 22q11.2 microdeletion","volume":"49","author":"Jaspers Faijer-Westerink","year":"2025","journal-title":"Int J Obes"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2020.100528","article-title":"22q11.2 microdeletion and increased risk for type 2 diabetes","volume":"26","author":"Van","year":"2020","journal-title":"EClinicalMedicine"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-21-1104","article-title":"Hypertriglyceridemia in young adults with a 22q11.2 microdeletion","volume":"187","author":"Blagojevic","year":"2022","journal-title":"Eur J Endocrinol"},{"key":"B27","unstructured":"Sorveglianza OKkio alla SALUTE -EpiCentro - Istituto Superiore di Sanit\u00e0\n          \n          \n            \n              Iss\n              E"},{"key":"B28","unstructured":"A focus on adolescent physical activity, eating behaviours, weight status and body image in Europe, central Asia and Canada | HBSC study"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1007\/BF03344156","article-title":"Italian cross-sectional growth charts for height, weight and BMI (2 to 20 yr)","volume":"29","author":"Cacciari","year":"2006","journal-title":"J Endocrinol Invest"},{"key":"B30","unstructured":"International consensus Guideline on Small for Gestational Age: Etiology and Management From Infancy to Early Adulthood - PubMed\n          \n          36635911"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1007\/BF03346475","article-title":"The effect of puberty on insulin resistance in obese children","volume":"32","author":"Pilia","year":"2009","journal-title":"J Endocrinol Invest"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-2674","article-title":"Strong effect of pubertal status on metabolic health in obese children: a longitudinal study","volume":"100","author":"Reinehr","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1111\/j.1467-789X.2010.00744.x","article-title":"Prevalence and risk factors of overweight and obesity among children and adolescents with intellectual disabilities","volume":"12","author":"Ma\u00efano","year":"2011","journal-title":"Obes Rev"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.164.13.1413","article-title":"Obesity and unhealthy life-years in adult Finns: an empirical approach","volume":"164","author":"Visscher","year":"2004","journal-title":"Arch Intern Med"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.573479","article-title":"Impact of psychotropic medication effects on obesity and the metabolic syndrome in people with serious mental illness","volume":"11","author":"Mazereel","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1002\/wps.20204","article-title":"Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder","volume":"14","author":"Correll","year":"2015","journal-title":"World Psychiatry"},{"key":"B37","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/S2215-0366(19)30416-X","article-title":"Comparative effects of 18 antipsychotics on metabolic function in patients with schizophrenia, predictors of metabolic dysregulation, and association with psychopathology: a systematic review and network meta-analysis","volume":"7","author":"Pillinger","year":"2020","journal-title":"Lancet Psychiatry"},{"key":"B38","doi-asserted-by":"publisher","first-page":"e94112","DOI":"10.1371\/journal.pone.0094112","article-title":"Almost all antipsychotics result in weight gain: A meta-analysis","volume":"9","author":"Bak","year":"2014","journal-title":"PloS One"},{"key":"B39","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1176\/appi.ajp.20230922","article-title":"Psychotropic drug-related weight gain and its treatment","volume":"181","author":"McIntyre","year":"2024","journal-title":"Am J Psychiatry"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2014.414","article-title":"An electronic health records study of long-term weight gain following antidepressant use","volume":"71","author":"Blumenthal","year":"2014","journal-title":"JAMA Psychiatry"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)61516-X","article-title":"Lithium toxicity profile: a systematic review and meta-analysis","volume":"379","author":"McKnight","year":"2012","journal-title":"Lancet"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-200822070-00002","article-title":"Antipsychotic-induced weight gain in chronic and first-episode psychotic disorders","volume":"22","author":"\u00c1lvarez-Jim\u00e9nez","year":"2008","journal-title":"CNS Drugs"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.ridd.2016.06.018","article-title":"Overweight and obesity in children and adolescents with Down syndrome\u2014prevalence, determinants, consequences, and interventions: A literature review","volume":"57","author":"Bertapelli","year":"2016","journal-title":"Res Dev Disabil"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1628796\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T10:05:56Z","timestamp":1770113156000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1628796\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,31]]},"references-count":43,"alternative-id":["10.3389\/fendo.2025.1628796"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1628796","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,31]]},"article-number":"1628796"}}